PCML
HRMY icon

Pavaki Capital Management LLC’s Harmony Biosciences HRMY Stock Holding History

Pavaki Capital Management LLC’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Hold
73,000
– – 0.93% 23
2026
Q1 		$2.04M Hold
73,000
– – 0.87% 25
2025
Q4 		$2.73M Buy
+73,000
New +$2.4M 1.07% 22

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Pavaki Capital Management LLC's HRMY Position: Q2 2026 in Review

Pavaki Capital Management LLC held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 73,000 shares worth $2.66M. The position accounts for 0.93% of the portfolio, ranked #23.

Pavaki Capital Management LLC first reported a position in HRMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.73M in Q4 2025. 120 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Pavaki Capital Management LLC held 73,000 shares of Harmony Biosciences worth $2.66M as of Q2 2026.
  • Pavaki Capital Management LLC left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up 0.93% of Pavaki Capital Management LLC's portfolio in Q2 2026, its #23 holding.
  • Pavaki Capital Management LLC first reported a position in Harmony Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Pavaki Capital Management LLC's Harmony Biosciences position peaked at $2.73M in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Pavaki Capital Management LLC's 13F filing for Q2 2026, filed 7 Aug 2026.